Building contrast-enhanced CT-based models for preoperatively predicting malignant potential and Ki67 expression of small intestine gastrointestinal stromal tumors (GISTs)

Springer Science and Business Media LLC - Tập 47 - Trang 3161-3173 - 2021
Miao-Ping Zhu1,2, Qiao-Ling Ding1, Jian-Xia Xu3, Chun-Yan Jiang1,4, Jing Wang5, Chao Wang1, Ri-Sheng Yu1
1Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Radiology, Hangzhou Women’s Hospital, Hangzhou, China
3Department of Radiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China
4Department of Radiology, People’s Hospital of Songyang County, Lishui, China
5Department of Radiology, Ningbo Medical Center Lihuili Hospital, Ningbo, China

Tóm tắt

To assess contrast-enhanced computed tomography (CE-CT) features for predicting malignant potential and Ki67 in small intestinal gastrointestinal stromal tumors (GISTs) and the correlation between them. We retrospectively analyzed the pathological and imaging data for 123 patients (55 male/68 female, mean age: 57.2 years) with a histopathological diagnosis of small intestine GISTs who received CE-CT followed by curative surgery from May 2009 to August 2019. According to postoperatively pathological and immunohistochemical results, patients were categorized by malignant potential and the Ki67 index, respectively. CT features were analyzed to be associated with malignant potential or the Ki67 index using univariate analysis, logistic regression and receiver operating curve analysis. Then, we explored the correlation between the Ki67 index and malignant potential by using the Spearman rank correlation. Based on univariate and multivariate analysis, a predictive model of malignant potential of small intestine GISTs, consisting of tumor size (p < 0.001) and presence of necrosis (p = 0.033), was developed with the area under the receiver operating curve (AUC) of 0.965 (95% CI, 0.915–0.990; p < 0.001), with 91.53% sensitivity, 96.87% specificity, 96.43% PPV, 92.54% NPV, 94.31% diagnostic accuracy. For high Ki67 expression, a model made up of tumor size (p = 0.051), presence of ulceration (p = 0.054) and metastasis (p = 0.001) may be the best predictive combination with an AUC of 0.785 (95% CI, 0.702–0.854; p < 0.001), 63.33% sensitivity, 76.34% specificity, 46.34% PPV, 86.59% NPV, 73.17% diagnostic accuracy. Ki67 index showed a moderate positive correlation with mitotic count (r = 0.578, p < 0.001), a weak positive correlation with tumor size (r = 0.339, p < 0.001) and with risk stratification (r = 0.364, p < 0.001). Features on CE-CT could preoperatively predict malignant potential and high Ki67 expression of small intestine GISTs, and Ki67 index may be a promising prognostic factor in predicting the prognosis of small intestine GISTs, independent of the risk stratification system.

Tài liệu tham khảo

Ren C, Wang S, Zhang S (2020) Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors. Cancer Imaging. 20(1):5. https://doi.org/10.1186/s40644-019-0284-7 Lee SJ, Song KB, Lee YJ, et al. (2019) Clinicopathologic Characteristics and Optimal Surgical Treatment of Duodenal Gastrointestinal Stromal Tumor. J Gastrointest Surg. 23(2):270–279. https://doi.org/10.1007/s11605-018-3928-1 Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 39(10):1411–1419. https://doi.org/10.1016/j.humpath.2008.06.025 Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK (2016) The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 19(1):3–14. https://doi.org/10.1007/s10120-015-0526-8 Lin JX, Chen QF, Zheng CH, et al. (2017) Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up. J Cancer Res Clin Oncol. 143(4):727–734. https://doi.org/10.1007/s00432-016-2334-x Li J, Ye Y, Wang J, Zhang B, Qin S, Shi Y et al (2017) Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor. Chin J Cancer Res. 29(4):281-293. https://doi.org/10.21147/j.issn.1000-9604.2017.04.01 Yin Y, Liu C, Zhang B, Wen Y, Yin Y (2019) Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors. Scientific Reports. 9(1):7257. https://doi.org/10.1038/s41598-019-43659-9 Chen T, Xu L, Dong X, et al. (2019) The roles of CT and EUS in the preoperative evaluation of gastric gastrointestinal stromal tumors larger than 2 cm. Eur Radiol. 29(5):2481–2489. https://doi.org/10.1007/s00330-018-5945-6 Wei SC, Xu L, Li WH, et al. (2020) Risk stratification in GIST: shape quantification with CT is a predictive factor. Eur Radiol. 30(4):1856–1865. https://doi.org/10.1007/s00330-019-06561-6 Feng C, Lu F, Shen Y, et al. (2018) Tumor heterogeneity in gastrointestinal stromal tumors of the small bowel: volumetric CT texture analysis as a potential biomarker for risk stratification. Cancer Imaging. 18(1):46. https://doi.org/10.1186/s40644-018-0182-4 Kurata Y, Hayano K, Ohira G, et al. (2018) Fractal analysis of contrast-enhanced CT images for preoperative prediction of malignant potential of gastrointestinal stromal tumor. Abdom Radiol (NY). 43(10):2659–2664. https://doi.org/10.1007/s00261-018-1526-z Su Q, Wang Q, Zhang H, et al. (2018) Computed tomography findings of small bowel gastrointestinal stromal tumors with different histologic risks of progression. Abdom Radiol (NY). 43(10):2651–2658. https://doi.org/10.1007/s00261-018-1511-6 Verde F, Hruban RH, Fishman EK (2017) Small Bowel Gastrointestinal Stromal Tumors: Multidetector Computed Tomography Enhancement Pattern and Risk of Progression. J Comput Assist Tomogr. 41(3):407–411. https://doi.org/10.1097/RCT.0000000000000526 Zhou Y, Hu W, Chen P, et al. (2017) Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors: A systematic review and meta-analysis. Medicine (Baltimore). 96(34): https://doi.org/10.1097/MD.0000000000007911 Li LT, Jiang G, Chen Q, Zheng JN (2015) Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 11(3):1566–1572. https://doi.org/10.3892/mmr.2014.2914 Li H, Ren G, Cai R, et al. (2018) A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor. Cancer Med. 7(9):4467–4474. https://doi.org/10.1002/cam4.1737 Zhao WY, Xu J, Wang M, et al. (2014) Prognostic value of Ki67 index in gastrointestinal stromal tumors. Int J Clin Exp Pathol. 7(5):2298–2304 Basilio-de-Oliveira RP, Pannain VL (2015) Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors. World J Gastroenterol. 21(22):6924–6930. https://doi.org/10.3748/wjg.v21.i22.6924 Cai PQ, Lv XF, Tian L, et al. (2015) CT Characterization of Duodenal Gastrointestinal Stromal Tumors. AJR Am J Roentgenol. 204(5):988–993. https://doi.org/10.2214/AJR.14.12870 Baheti AD, Shinagare AB, O’Neill AC, et al. (2015) MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol. 88(1053):20150085. https://doi.org/10.1259/bjr.20150085 Feng F, Wang F, Wang Q, et al. (2019) Clinicopathological Features and Prognosis of Gastrointestinal Stromal Tumor Located in the Jejunum and Ileum. Dig Surg. 36(2):153–157. https://doi.org/10.1159/000487147 Vasconcelos RN, Dolan SG, Barlow JM, et al. (2017) Impact of CT enterography on the diagnosis of small bowel gastrointestinal stromal tumors. Abdom Radiol (NY). 42(5):1365–1373. https://doi.org/10.1007/s00261-016-1033-z Xing GS, Wang S, Sun YM, et al. (2015) Small Bowel Stromal Tumors: Different Clinicopathologic and Computed Tomography Features in Various Anatomic Sites. PLoS One. 10(12): https://doi.org/10.1371/journal.pone.0144277 Wang C, Li H, Jiaerken Y, et al. (2019) Building CT Radiomics-Based Models for Preoperatively Predicting Malignant Potential and Mitotic Count of Gastrointestinal Stromal Tumors. Transl Oncol. 12(9):1229–1236. https://doi.org/10.1016/j.tranon.2019.06.005 Yi M, Xia L, Zhou Y, et al. (2019) Prognostic value of tumor necrosis in gastrointestinal stromal tumor: A meta-analysis. Medicine (Baltimore). 98(17): https://doi.org/10.1097/MD.0000000000015338 Liu X, Qiu H, Zhang P, Feng X, Chen T, Li Y et al (2018) Ki-67 labeling index may be a promising indicator to identify “very high-risk” gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients. Hum Pathol. 74(17-24. https://doi.org/10.1016/j.humpath.2017.09.003 Zhang QW, Gao YJ, Zhang RY, et al. (2020) Personalized CT-based radiomics nomogram preoperative predicting Ki-67 expression in gastrointestinal stromal tumors: a multicenter development and validation cohort. Clin Transl Med. 9(1):12. https://doi.org/10.1186/s40169-020-0263-4 Belev B, Brcic I, Prejac J, et al. (2013) Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors. World J Gastroenterol. 19(4):523–527. https://doi.org/10.3748/wjg.v19.i4.523